Patel Sushil 4

4 · Replimune Group, Inc. · Filed Apr 7, 2026

AI-generated summary of this filing

Updated Apr 8, 2026

Replimune (REPL) CEO Sushil Patel Receives Stock Awards

What Happened

Sushil Patel, CEO of Replimune Group, received equity awards on April 1, 2026: 251,240 restricted stock units (RSUs) and 376,860 derivative awards (stock-option–style grant). Both awards were reported at $0.00 per share (i.e., granted, not purchased), for a combined total of 628,100 shares subject to future vesting/settlement. This is an award/grant transaction (code A), not a sale.

Key Details

Transaction date: 2026-04-01; Form 4 filed: 2026-04-07 (late filing; see below).
Grant amounts and reported price:
- 251,240 RSUs @ $0.00 (F1)
- 376,860 derivative award @ $0.00 (F2)
Shares owned after the transaction: not specified in the provided filing excerpt.
Vesting notes:
- F1 (RSUs): 25% vest May 15, 2027; remaining RSUs vest in three approximately equal annual installments through May 15, 2030, subject to continued service.
- F2 (derivative/option): 25% of shares underlying the option vest April 1, 2027; remaining shares vest in ~36 equal monthly installments thereafter.
Filing timeliness: The Form 4 was filed late; the filing states the delay was due to an inadvertent administrative error.

Context

These awards are standard compensation grants and represent future rights to shares contingent on vesting/settlement; they are not open‑market purchases or sales. The derivative award follows a multi-year vesting schedule (partial cliff then monthly vesting). A late Form 4 does not change the nature of the grant but reduces disclosure timeliness for investors.

Form 4

Period: 2026-04-01

DirectorChief Executive Officer

Transactions

Award
Common Stock
[F1]
2026-04-01+251,240→ 784,816 total
Award
Employee Stock Option (right to buy)
[F2]
2026-04-01+376,860→ 376,860 total
Exercise: $7.61Exp: 2036-04-01→ Common Stock (376,860 underlying)

Footnotes (2)

[F1]Represents shares of the Issuer's common stock issuable upon settlement of restricted stock units ("RSUs") granted to the Reporting Person. Each RSU represents a contingent right to receive one share of the Issuer's common stock. 25% of the RSUs will vest on May 15, 2027 and the remainder will vest in three approximately equal annual installments thereafter until May 15, 2030, subject to the Reporting Person's continuous service to the Issuer.
[F2]25% of the shares underlying this stock option vest on April 1, 2027, and the remainder of the shares underlying this stock option vest in 36 approximately equal monthly installments thereafter.

Signature

/s/ Shawn Glidden, attorney-in-fact|2026-04-07

1 file